Xiaoting Hu

Array ( [id] => 397489 [patent_doc_number] => 07294458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-13 [patent_title] => 'Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients' [patent_app_type] => utility [patent_app_number] => 10/695846 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13675 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294458.pdf [firstpage_image] =>[orig_patent_app_number] => 10695846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295033 [patent_doc_number] => 20040213799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/686943 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19774 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213799.pdf [firstpage_image] =>[orig_patent_app_number] => 10686943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034512 [patent_doc_number] => 20050033022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Fusion proteins comprising HIV-1 Tat and/or Nef proteins' [patent_app_type] => utility [patent_app_number] => 10/687060 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6202 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033022.pdf [firstpage_image] =>[orig_patent_app_number] => 10687060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7471567 [patent_doc_number] => 20040096972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Chimeric plasmid comprising a replicative retroviral genome, and uses' [patent_app_type] => new [patent_app_number] => 10/677558 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8150 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096972.pdf [firstpage_image] =>[orig_patent_app_number] => 10677558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117399 [patent_doc_number] => 20050070700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Equine arteritis virus vaccine' [patent_app_type] => utility [patent_app_number] => 10/675444 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25914 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070700.pdf [firstpage_image] =>[orig_patent_app_number] => 10675444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269798 [patent_doc_number] => 20040058316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Use of recombinant antigens to determine the immune status of an animal' [patent_app_type] => new [patent_app_number] => 10/670695 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19477 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058316.pdf [firstpage_image] =>[orig_patent_app_number] => 10670695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089632 [patent_doc_number] => 20050009745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'TSG101 as inhibitor of HIV production' [patent_app_type] => utility [patent_app_number] => 10/666997 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20808 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009745.pdf [firstpage_image] =>[orig_patent_app_number] => 10666997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7407688 [patent_doc_number] => 20040106136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Method for testing drug susceptibility of HIV' [patent_app_type] => new [patent_app_number] => 10/663360 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 30518 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106136.pdf [firstpage_image] =>[orig_patent_app_number] => 10663360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150941 [patent_doc_number] => 20040171568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Antiviral oligonucleotides targeting HIV' [patent_app_type] => new [patent_app_number] => 10/661099 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35304 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171568.pdf [firstpage_image] =>[orig_patent_app_number] => 10661099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376817 [patent_doc_number] => 07311915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Method of producing an HIV-1 immune response' [patent_app_type] => utility [patent_app_number] => 10/659324 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7285 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/311/07311915.pdf [firstpage_image] =>[orig_patent_app_number] => 10659324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333168 [patent_doc_number] => 20040131594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/653624 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19718 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131594.pdf [firstpage_image] =>[orig_patent_app_number] => 10653624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7389070 [patent_doc_number] => 20040082934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Method of controlling pharmacokinetics of immunomodulatory compounds' [patent_app_type] => new [patent_app_number] => 10/650039 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8478 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082934.pdf [firstpage_image] =>[orig_patent_app_number] => 10650039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164857 [patent_doc_number] => 20040076640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Vaccine compositions against infectious pathologies for mammals' [patent_app_type] => new [patent_app_number] => 10/642763 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4835 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076640.pdf [firstpage_image] =>[orig_patent_app_number] => 10642763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011348 [patent_doc_number] => 20050065064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Identification of allosteric peptide agonists of CXCR4' [patent_app_type] => utility [patent_app_number] => 10/637911 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7347 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065064.pdf [firstpage_image] =>[orig_patent_app_number] => 10637911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116716 [patent_doc_number] => 20050070017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications' [patent_app_type] => utility [patent_app_number] => 10/636730 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 176 [patent_figures_cnt] => 176 [patent_no_of_words] => 40422 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10636730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977930 [patent_doc_number] => 20050287648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/523038 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 65405 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287648.pdf [firstpage_image] =>[orig_patent_app_number] => 10523038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966416 [patent_doc_number] => 20050233313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Methods and reagents for identifying inhibitors of viral protease activity' [patent_app_type] => utility [patent_app_number] => 10/521381 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18340 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233313.pdf [firstpage_image] =>[orig_patent_app_number] => 10521381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060981 [patent_doc_number] => 20050003342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Viral marker' [patent_app_type] => utility [patent_app_number] => 10/626832 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14701 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003342.pdf [firstpage_image] =>[orig_patent_app_number] => 10626832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793467 [patent_doc_number] => 20060014148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Igg fc/hiv-gp120/c3d fusion protien' [patent_app_type] => utility [patent_app_number] => 10/518523 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3267 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014148.pdf [firstpage_image] =>[orig_patent_app_number] => 10518523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291803 [patent_doc_number] => 20040110922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Chimeric proteins for prevention and treatment of hiv infection' [patent_app_type] => new [patent_app_number] => 10/466836 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12258 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110922.pdf [firstpage_image] =>[orig_patent_app_number] => 10466836 [rel_patent_id] =>[rel_patent_doc_number] =>)